Table 4.

Plasma fatty acid profile in neonatal calves born to cows supplemented with saturated fat, flaxseed oil, or fish oil

FA, %	Treatment1			SEM	P-value
	CTL	FLX	FO
C14:02	5.80	4.26	5.43	0.58	0.17
C16:02	34.76	31.34	32.77	1.35	0.25
C16:12	1.14	1.15	0.86	0.10	0.096
C16:22	4.19	4.22	4.00	0.23	0.78
C16:32	0.51	0.62	0.54	0.07	0.49
C18:02	10.42	11.10	10.34	0.43	0.41
C18:1n-92	22.83	24.53	24.16	1.02	0.47
C18:1n-72	2.22	2.39	2.12	0.17	0.52
C18:2n-62	14.19	16.18	15.10	1.65	0.69
C18:3n-3 (ALA)2	1.12	1.24	1.16	0.07	0.46
C20:4n-62	2.66	3.18	2.86	0.22	0.29
C20:5n-3 (EPA)2	0.02b	0.01b	0.13a	0.02	0.002
C22:5n-32	0.02b	0.02b	0.20a	0.03	0.001
C22:6n-3 (DHA)2	0.04b	0.01b	0.17a	0.03	0.002
SFA	49.35	46.70	48.53	1.28	0.34
MUFA	26.33	28.07	27.14	1.15	0.56
PUFA	22.67	25.22	24.32	1.90	0.62
Total n-3 FAs	1.19b	1.29ab	1.59a	0.11	0.05
Total n-6 FAs	16.85	19.19	17.96	1.82	0.66
n-6:n-3 FAs ratio	14.20	14.88	11.43	1.01	0.06

¹Dairy cows at d 257 of pregnancy were divided into three nutritional groups supplemented with (i) CTL – encapsulated saturated fat, (ii) FLX – encapsulated flaxseed oil providing ALA, or (iii) FO – encapsulated fish oil providing EPA and DHA

²C14:0 to C22:6n-3: % of total FAs identified

ALA Alpha-linolenic acid, DHA Docosahexaenoic acid, EPA Eicosapentaenoic acid, FAs Fatty acids, SFA Saturated FA, MUFA Monounsaturated FA, PUFA Polyunsaturated FA

^a,bValues with different superscript letters in a row are significantly different at P ≤ 0.05